SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes

Irwin Jungreis, Rachel Sealfon, Manolis Kellis

Introduction

Despite the global impact of the COVID-19 pandemic, the exact protein-coding capacity of the SARS-CoV-2 genome remained a subject of debate during the early stages of the crisis. The virus utilizes a compact RNA genome where genes often overlap in different reading frames, making it difficult to distinguish functional proteins from non-functional genetic noise. Resolving this "parts list" is critical for understanding viral biology and interpreting the functional significance of emerging mutations. This study employs comparative genomics to provide a high-confidence gene set and characterize the evolutionary pressures shaping the virus.

Methods and Datasets

To distinguish functional genes from accidental open reading frames (ORFs), researchers analyzed 44 complete Sarbecovirus genomes, including SARS-CoV-2, SARS-CoV, and 42 related bat-infecting strains. This evolutionary distance provided a "Goldilocks" window—diverse enough to show selective signals but conserved enough for accurate alignment.

The primary analytical tool used was PhyloCSF (Phylogenetic Codon Substitution Frequencies), which identifies protein-coding signatures by quantifying the preference for synonymous mutations over non-synonymous ones. Additionally, the FRESCo tool was used to detect "synonymous constraint," identifying regions where the RNA sequence is conserved for secondary functions, such as structural elements or overlapping coding frames. These findings were cross-referenced with 1,875 single-nucleotide variants (SNVs) from early pandemic isolates to compare long-term evolutionary trends with real-time adaptation.

The High-Confidence Gene Set

By applying these rigorous evolutionary metrics, the study finalized a set of 13 protein-coding genes: 1a, 1ab, S, 3a, 3c, E, M, 6, 7a, 7b, 8, N, and 9b.

Comparative genomics analysis of SARS-CoV-2 protein-coding genes using PhyloCSF and synonymous constraint signatures.

Key findings regarding the gene set include:

  • De-annotation of Suspected Genes: Several ORFs frequently cited in early literature, including ORF10, ORF9c, 3b, and 3d, were found to lack protein-coding signatures. ORF10, in particular, appears to be a highly conserved RNA pseudoknot structure involved in replication rather than a protein-coding gene.
  • Confirmation of ORF3c: The study confirmed ORF3c as a functional, novel gene that overlaps with ORF3a. Its conservation across the Sarbecovirus lineage suggests it plays a vital role in the viral life cycle.
  • Exhaustive Search: The analysis concluded that no other protein-coding genes remain to be discovered in the SARS-CoV-2 genome.

Evolutionary Dynamics and Pandemic Mutations

The study revealed a strong correlation (0.70) between long-term evolutionary constraints and the mutations observed during the pandemic. However, the deviations from this trend provide the most significant insights into how the virus is adapting to human hosts.

Adaptation and Immune Avoidance

One of the most notable findings involves the Spike D614G mutation. This variant disrupts an amino acid residue that has been perfectly conserved across Sarbecoviruses for millions of years, signaling a specific adaptation to optimize human-to-human transmission.

Similarly, the Nucleocapsid (N) protein exhibited significantly higher mutation rates (21%) than predicted by its historical conservation (11%). A specific 20-amino-acid hotspot within the N protein, overlapping with a predicted B-cell epitope, showed a cluster of mutations. This suggests the virus is under intense selective pressure to evade the human immune system.

Evolutionary Deceleration

In contrast, the S1 subunit of the Spike protein and nsp3 showed fewer mutations than expected. This "deceleration" might indicate that these regions reached a fitness peak early in the pandemic or adapted to humans prior to the first widely tracked outbreaks.

Conclusion

By resolving the SARS-CoV-2 gene set and mapping evolutionary constraints, this research provides a foundational resource for COVID-19 biology. The identification of 1,394 synonymously-constrained codons highlights regions where the RNA structure itself is vital, offering new targets for therapeutic intervention. Furthermore, the ability to distinguish between routine genetic drift and adaptive "rule-breaking" mutations allows researchers to better prioritize variants of concern as the virus continues to evolve.

Summary updated

Abstract

Despite its overwhelming clinical importance, the SARS-CoV-2 gene set remains unresolved, hindering dissection of COVID-19 biology. Here, we use comparative genomics to provide a high-confidence protein-coding gene set, characterize protein-level and nucleotide-level evolutionary constraint, and prioritize functional mutations from the ongoing COVID-19 pandemic. We select 44 complete Sarbecovirus genomes at evolutionary distances ideally-suited for protein-coding and non-coding element identification, create whole-genome alignments, and quantify protein-coding evolutionary signatures and overlapping constraint. We find strong protein-coding signatures for all named genes and for 3a, 6, 7a, 7b, 8, 9b, and also ORF3c, a novel alternate-frame gene. By contrast, ORF10, and overlapping-ORFs 9c, 3b, and 3d lack protein-coding signatures or convincing experimental evidence and are not protein-coding. Furthermore, we show no other protein-coding genes remain to be discovered. Cross-strain and within-strain evolutionary pressures largely agree at the gene, amino-acid, and nucleotide levels, with some notable exceptions, including fewer-than-expected mutations in nsp3 and Spike subunit S1, and more-than-expected mutations in Nucleocapsid. The latter also shows a cluster of amino-acid-changing variants in otherwise-conserved residues in a predicted B-cell epitope, which may indicate positive selection for immune avoidance. Several Spike-protein mutations, including D614G, which has been associated with increased transmission, disrupt otherwise-perfectly-conserved amino acids, and could be novel adaptations to human hosts. The resulting high-confidence gene set and evolutionary-history annotations provide valuable resources and insights on COVID-19 biology, mutations, and evolution.
BibTeX
@inproceedings{jungreis2021sars,
  author = {Irwin Jungreis and Rachel Sealfon and Manolis Kellis},
  title = {{SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes}},
  booktitle = {Nature Communications},
  year = {2021},
  doi = {10.1038/s41467-021-22905-7},
}
Figure